Koers Getinge AB Other OTC
Aandelen
GNGBY
US37427X1046
Medische apparatuur, benodigdheden & distributie
Omzet 2024 * | 34,19 mld. 3,13 mld. 2,92 mld. | Omzet 2025 * | 35,85 mld. 3,28 mld. 3,06 mld. | Marktkapitalisatie | 64,01 mld. 5,86 mld. 5,47 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 2,84 mld. 260 mln. 243 mln. | Nettowinst (verlies) 2025 * | 3,31 mld. 303 mln. 283 mln. | EV/omzet 2024 * | 2,06 x |
Nettoschuld 2024 * | 6,37 mld. 584 mln. 545 mln. | Nettoschuld 2025 * | 4,3 mld. 394 mln. 367 mln. | EV/omzet 2025 * | 1,91 x |
K/w-verhouding 2024 * |
23
x | K/w-verhouding 2025 * |
19,4
x | Werknemers | - |
Dividendrendement 2024 * |
2,04% | Dividendrendement 2025 * |
2,26% | Vrij verhandelbaar | 79,06% |
Recentste transcriptie over Getinge AB
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 52 | 01-05-17 | |
Agneta Palmér
DFI | Director of Finance/CFO | - | 15-09-22 |
Johan Malmquist
CHM | Chairman | 63 | 01-01-97 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Johan Bygge
BRD | Director/Board Member | 68 | 01-01-07 |
Director/Board Member | 73 | 01-01-89 | |
Johan Malmquist
CHM | Chairman | 63 | 01-01-97 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+73,09% | 12,38 mld. | |
-18,39% | 7,61 mld. | |
+14,33% | 7,11 mld. | |
+11,77% | 5,35 mld. | |
+29,65% | 4,63 mld. | |
-17,52% | 4,02 mld. | |
-35,92% | 2,16 mld. | |
+1,24% | 2,01 mld. | |
+4,85% | 1,88 mld. |